Cargando…

Ticagrelor Use in Acute Myocardial Infarction: Insights From the National Cardiovascular Data Registry

BACKGROUND: Ticagrelor is a P2Y(12) receptor inhibitor with superior clinical efficacy compared with clopidogrel. However, it is associated with reduced efficacy when combined with a high‐dose aspirin. METHODS AND RESULTS: Patients in the acute coronary treatment and intervention outcomes network (A...

Descripción completa

Detalles Bibliográficos
Autores principales:	Basra, Sukhdeep S., Wang, Tracy Y., Simon, DaJuanicia N., Chiswell, Karen, Virani, Salim S., Alam, Mahboob, Nambi, Vijay, Denktas, Ali E., Deswal, Anita, Bozkurt, Biykem, Ballantyne, Christie M., Peterson, Eric D., Jneid, Hani
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6220549/ https://www.ncbi.nlm.nih.gov/pubmed/29886424 http://dx.doi.org/10.1161/JAHA.117.008125

Ejemplares similares

Severity of hypoxia modulates effect of CPAP on myocardial stress as measured by highly sensitive troponin T
por: Sharafkhaneh, Amir, et al.
Publicado: (2015)

Acute Tubular Injury in a Patient on a Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor
por: Pickett, June K., et al.
Publicado: (2020)

Non-traditional risk factors and the risk of myocardial infarction in the young in the US population-based cohort
por: Krittanawong, Chayakrit, et al.
Publicado: (2020)

Cardiac Surgery During the Coronavirus Disease 2019 Pandemic: Perioperative Considerations and Triage Recommendations
por: Patel, Vivek, et al.
Publicado: (2020)

Temporal Trends in Care and Outcomes of Patients Receiving Fibrinolytic Therapy Compared to Primary Percutaneous Coronary Intervention: Insights From the Get With The Guidelines Coronary Artery Disease (GWTG‐CAD) Registry
por: Hira, Ravi S., et al.
Publicado: (2016)

Is 2015 the Primetime Year for Prehypertension? Prehypertension: A Cardiovascular Risk Factor or Simply a Risk Marker?
por: Habib, Gabriel B., et al.
Publicado: (2015)

Temporal Trends in Lipoprotein(a) Concentrations: The Atherosclerosis Risk in Communities Study
por: Deshotels, Matthew R., et al.
Publicado: (2022)

Integrative Genetic Approach Facilitates Precision Strategies for Acute Myocardial Infarction
por: Khawaja, Muzamil, et al.
Publicado: (2023)

Evaluation of Aspirin and Statin Therapy Use and Adherence in Patients With Premature Atherosclerotic Cardiovascular Disease
por: Mahtta, Dhruv, et al.
Publicado: (2020)

Effect of increasing age on percutaneous coronary intervention vs coronary artery bypass grafting in older adults with unprotected left main coronary artery disease: A meta‐analysis and meta‐regression
por: Khan, Mahin R., et al.
Publicado: (2019)

Extended Duration of Dual‐Antiplatelet Therapy After Percutaneous Coronary Intervention: How Long Is Too Long?
por: Howard, Charles E., et al.
Publicado: (2019)

Southern Saskatchewan Ticagrelor Registry experience
por: Dehghani, Payam, et al.
Publicado: (2014)

Provider Specialty and Atrial Fibrillation Treatment Strategies in United States Community Practice: Findings From the ORBIT‐AF Registry
por: Fosbol, Emil L., et al.
Publicado: (2013)

A dataset to assess providers׳ knowledge and attitudes towards the 2013 American College of Cardiology/American Heart Association Cholesterol Management Guideline
por: Pokharel, Yashashwi, et al.
Publicado: (2016)

Ultrasound in Cardiovascular Risk Prediction: Don't Forget the Plaque!
por: Nambi, Vijay, et al.
Publicado: (2013)

Identifying Differences: A Key Step in Precision Cardiovascular Disease Prevention
por: Al Rifai, Mahmoud, et al.
Publicado: (2022)

E-cigarette Use and Risk Behaviors among Lesbian, Gay, Bisexual, and Transgender Adults: The Behavioral Risk Factor Surveillance System (BRFSS) Survey
por: Al Rifai, Mahmoud, et al.
Publicado: (2020)

Catheter Ablation of Atrial Fibrillation in U.S. Community Practice—Results From Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF)
por: Holmqvist, Fredrik, et al.
Publicado: (2015)

Regional Variations in Heart Failure Quality and Outcomes: Get With The Guidelines–Heart Failure Registry
por: Cunningham, Luke C., et al.
Publicado: (2021)

Corrigendum for “Acute Aortic Valve Rupture From Infective Endocarditis”
por: Ansari, Julia, et al.
Publicado: (2013)

Acute Aortic Valve Rupture From Infective Endocarditis After Transrectal Prostate Biopsy: A Call to Revise the AHA Guidelines for Prevention of Infective Endocarditis
por: Ansari, Julia, et al.
Publicado: (2013)

Association of Cardiovascular Disease and Pancreatitis: What Came First, the Chicken or the Egg?
por: Chen, Bing, et al.
Publicado: (2023)

High‐Sensitivity Cardiac Troponin: From Patient Phenotypes to Clinical Events in Patients With Heart Failure With Preserved Ejection Fraction
por: Bozkurt, Biykem
Publicado: (2018)

President's Message
por: Bozkurt, Biykem
Publicado: (2020)

Factor Xa Inhibition, A New Strategy for Prevention of Adverse Cardiac Remodeling in Early Stages?
por: Bozkurt, Biykem
Publicado: (2020)

Early Adoption of Dabigatran and Its Dosing in US Patients With Atrial Fibrillation: Results From the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation
por: Steinberg, Benjamin A., et al.
Publicado: (2013)

PCSK9 Inhibitors in the Management of Cardiovascular Risk: A Practical Guidance
por: Jia, Xiaoming, et al.
Publicado: (2022)

2022 AHA/ACC Key Data Elements and Definitions for Cardiovascular and Noncardiovascular Complications of COVID-19: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards
por: Bozkurt, Biykem, et al.
Publicado: (2022)

Variability in Nonvitamin K Oral Anticoagulant Dose Eligibility and Adjustment According to Renal Formulae and Clinical Outcomes in Patients With Atrial Fibrillation With and Without Chronic Kidney Disease: Insights From ORBIT‐AF II
por: Yao, Ren Jie Robert, et al.
Publicado: (2023)

Facility-Level Variation in Cardiac Stress Test Use Among Patients With Diabetes: Findings From the Veterans Affairs National Database
por: Mahtta, Dhruv, et al.
Publicado: (2020)

Ticagrelor: A Rare, Delayed Case of Angioedema
por: Walia, Jasmit, et al.
Publicado: (2023)

Racial and Ethnic Differences in Presentation and Outcomes for Patients Hospitalized With COVID-19: Findings From the American Heart Association’s COVID-19 Cardiovascular Disease Registry
por: Rodriguez, Fatima, et al.
Publicado: (2020)

Aortic Stenosis Phenotypes and Precision Transcatheter Aortic Valve Implantation
por: Khawaja, Muzamil, et al.
Publicado: (2023)

Joint HFSA/ACC/AHA Statement Addresses Concerns Re: Using RAAS Antagonists in COVID-19
por: Bozkurt, Biykem, et al.
Publicado: (2020)

Representation of women in heart failure clinical trials: Barriers to enrollment and strategies to close the gap
por: Reza, Nosheen, et al.
Publicado: (2022)

Endpoints in Heart Failure Drug Development
por: Hussain, Aliza, et al.
Publicado: (2022)

Ticagrelor Reduces Thromboinflammatory Markers in Patients With Pneumonia
por: Sexton, Travis R., et al.
Publicado: (2018)

Alterations in Lipids and Adipocyte Hormones in Female-to-Male Transsexuals
por: Chandra, Prakash, et al.
Publicado: (2010)

Seasonal Variation of Atrial Fibrillation Admission and Quality of Care in the United States
por: Sheehy, Shanshan, et al.
Publicado: (2022)

Unraveling the pharmacokinetic interaction of ticagrelor and MEDI2452 (Ticagrelor antidote) by mathematical modeling
por: Almquist, J, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_b0mri42sn8qollvius7eqd0u3o